The Effects of alendronate for reducing the risk of osteoporotic vertebral fracture
Tang Ha
Abstract
Tang Ha
Abstract
Osteoporosis has became a serious public health problem in the world. Nowadays it has been paid closely attention to the prevention and treatment of osteoporosis and osteoporotic fracture. Alendronate is a common therapy to treat osteoporosis, which has an evident effect on increasing BMD, and reducing osteoporotic vertebral fractures and new fractures. Compared with other antiresorptive agents, alendronate has a stronger effect on increasing BMD. However, there is no strong evidence that alendronate could prevent adjacent vertebral fracture after vertebral augmentation.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Osteoporosis has became a serious public health problem in the world. Nowadays it has been paid closely attention to the prevention and treatment of osteoporosis and osteoporotic fracture. Alendronate is a common therapy to treat osteoporosis, which has an evident effect on increasing BMD, and reducing osteoporotic vertebral fractures and new fractures. Compared with other antiresorptive agents, alendronate has a stronger effect on increasing BMD. However, there is no strong evidence that alendronate could prevent adjacent vertebral fracture after vertebral augmentation.
Key concepts: Osteoporosis, Medicine, Osteoporotic fracture, Dentistry, Internal medicine, Bone mineral